These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 1367060)

  • 1. Nonperfused attachment systems for cell cultivation.
    Elliott AY
    Bioprocess Technol; 1990; 10():207-16. PubMed ID: 1367060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of a mink enteritis vaccine production process in stirred-tank reactor and Wave Bioreactor microcarrier culture in 1-10 L scale.
    Hundt B; Best C; Schlawin N; Kassner H; Genzel Y; Reichl U
    Vaccine; 2007 May; 25(20):3987-95. PubMed ID: 17391818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Communicating vessel systems for mass cell culture of anchorage dependent cells.
    Skoda R; Pakos V; Hörmann A; Späth O; Johansson A
    Dev Biol Stand; 1979; 42():121-6. PubMed ID: 467794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Appropriate mammalian expression systems for biopharmaceuticals.
    Werner RG; Noé W; Kopp K; Schlüter M
    Arzneimittelforschung; 1998 Aug; 48(8):870-80. PubMed ID: 9748718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suspension culture of mammalian cells.
    Birch JR; Arathoon R
    Bioprocess Technol; 1990; 10():251-70. PubMed ID: 1367062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upflow anaerobic sludge blanket reactor--a review.
    Bal AS; Dhagat NN
    Indian J Environ Health; 2001 Apr; 43(2):1-82. PubMed ID: 12397675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effective manufacture of an allogeneic GM-CSF-secreting breast tumor vaccine in an academic cGMP facility.
    Davis-Sproul JM; Harris MP; Davidson NE; Kobrin BJ; Jaffee EM; Emens LA
    Cytotherapy; 2005; 7(1):46-56. PubMed ID: 16040383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A perfusion culture system for virus vaccine manufacture in diploid cell cultures.
    Mann GF; de Mucha Macías J
    Bull Pan Am Health Organ; 1976; 10(3):205-11. PubMed ID: 187274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of new cell lines for animal cell biotechnology.
    MacDonald C
    Crit Rev Biotechnol; 1990; 10(2):155-78. PubMed ID: 2202521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Industrial processes with animal cells.
    Kretzmer G
    Appl Microbiol Biotechnol; 2002 Jul; 59(2-3):135-42. PubMed ID: 12111138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum-free influenza virus production avoiding washing steps and medium exchange in large-scale microcarrier culture.
    Genzel Y; Fischer M; Reichl U
    Vaccine; 2006 Apr; 24(16):3261-72. PubMed ID: 16472544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuously Cultured Tissue Cells and Viral Vaccines: Potential advantages may be realized and potential hazards obviated by careful planning and monitoring.
    Committee on Tissue Culture Viruses and Vaccines
    Science; 1963 Jan; 139(3549):15-20. PubMed ID: 17752015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum-free cultivation of anchorage-dependent cells on microcarrier: effective production of human macrophage colony-stimulating factor.
    Satoh S; Kobayashi J; Mizoguchi J; Nogawa M; Otani M
    Cytotechnology; 1991; 5 Suppl 2():S95-114. PubMed ID: 1367256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substitution of glutamine by pyruvate to reduce ammonia formation and growth inhibition of mammalian cells.
    Genzel Y; Ritter JB; König S; Alt R; Reichl U
    Biotechnol Prog; 2005; 21(1):58-69. PubMed ID: 15903241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large-scale animal cell culture: a biological perspective.
    Oka MS; Rupp RG
    Bioprocess Technol; 1990; 10():71-92. PubMed ID: 1367073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microcarrier-based MDCK cell culture system for the production of influenza H5N1 vaccines.
    Hu AY; Weng TC; Tseng YF; Chen YS; Wu CH; Hsiao S; Chou AH; Chao HJ; Gu A; Wu SC; Chong P; Lee MS
    Vaccine; 2008 Oct; 26(45):5736-40. PubMed ID: 18761387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The development and use of microcarrier and glass sphere culture techniques for the production of herpes simplex viruses.
    Griffiths JB; Thornton B; McEntee I
    Dev Biol Stand; 1981; 50():103-10. PubMed ID: 6281104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Karyology and tumorigenicity testing requirements: past, present and future.
    Petricciani JC; Horaud FN
    Dev Biol Stand; 1998; 93():5-13. PubMed ID: 9737371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a robust, versatile, and scalable inoculum train for the production of a DNA vaccine.
    Okonkowski J; Kizer-Bentley L; Listner K; Robinson D; Chartrain M
    Biotechnol Prog; 2005; 21(4):1038-47. PubMed ID: 16080681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro cultivation of epithelial cells derived from tumors of the human urinary tract.
    Elliott AY; Bronson DL; Stein N; Fraley EE
    Cancer Res; 1976 Feb; 36(2 Pt 1):365-9. PubMed ID: 944089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.